Springer Character continues to be neutral with regards to jurisdictional claims in printed maps and institutional affiliations. The Preliminary dose in the sublingual tablet is always 100 mcg besides in patients getting the transmucosal lozenge - see dose adjustment segment for Preliminary dosin